Home > Healthcare > Medical Services > Diagnostic Services > HbA1c Testing Market

HbA1c Testing Market Size

  • Report ID: GMI9631
  • Published Date: May 2024
  • Report Format: PDF

HbA1c Testing Market Size

HbA1c Testing Market size was valued at around USD 2.3 billion in 2023 and is estimated to grow at 8.6% CAGR from 2024 to 2032. HbA1c testing, also known as glycated hemoglobin testing, is a common and important blood test used to measure the average level of blood glucose (sugar) over the past two to three months. This test is primarily used to diagnose and monitor diabetes.

 

HbA1c testing is a crucial tool in the management of diabetes, providing valuable insights into long-term blood glucose control and helping to prevent complications by enabling timely and appropriate medical interventions. This test is especially beneficial for drivers with diabetes, as maintaining optimal blood glucose control is essential for safe driving. Poorly managed diabetes can lead to fluctuating blood sugar levels, potentially causing symptoms like dizziness, confusion, or loss of consciousness, which can be dangerous when operating a vehicle. Regular HbA1c testing helps drivers monitor their glucose control, adjust their treatment plans accordingly, and reduce the risk of diabetes-related complications that could impair their ability to drive safely. Ensuring HbA1c levels are within the recommended range enhances overall health and safety, both on and off the road.
 

Furthermore, according to the International Diabetes Federation, the number of adults living with diabetes is projected to increase substantially in the coming decades, fueling demand for reliable and efficient rapid diagnostic tools like HbA1c tests. Another major driver is the increasing awareness of the importance of early diagnosis and regular monitoring of diabetes to prevent complications. As both healthcare providers and patients recognize the benefits of maintaining tight blood glucose control, the adoption of HbA1c testing as a standard practice is expanding. Additionally, advancements in medical technology have led to the development of more accurate, convenient, and cost-effective HbA1c testing methods, further boosting market growth.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Market size for HbA1c testing was valued at USD 2.3 billion in 2023 and is estimated to grow at 8.6% CAGR from 2024 to 2032 due to factors, such as the increasing prevalence of diabetes and technological advancements, alongside the development of novel testing methodologies.

The point-of-care (POC) testing segment of the HbA1c testing market is forecasted to reach USD 3.5 billion by 2032 due to the increasing demand for accessible diabetes management, advancements in testing technology, and personalized healthcare.

The immunoassays segment of the HbA1c testing industry accounted for USD 817.1 million in 2023 due to rising diabetes prevalence, technological advancements, and the demand for efficient point-of-care solutions.

Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Ceragem Medisys Inc., Danaher Corporation, EKF Diagnostics, F. Hoffmann-La Roche Ltd., HUMAN, Menarini Diagnostics s.r.l, and PTS Diagnostics, among others.

HbA1c Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 220
  • Countries covered: 23
  • Pages: 230
 Download Free Sample